Research

Displaying 1 - 10 of 229 Articles
MS Ireland Logo
MS Ireland
19 Apr 2021

Tysabri Injections licensed in Europe

The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.

MS Ireland Logo
MS Ireland
30 Mar 2021

Octopus Trial for progressive MS

UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.

Top